z-logo
open-access-imgOpen Access
Is a Diabetes Mellitus–Linked Amino Acid Signature Associated With β-Blocker–Induced Impaired Fasting Glucose?
Author(s) -
Rhonda M. CooperDeHoff,
Wei Hou,
Liming Weng,
Rebecca Baillie,
Amber L. Beitelshees,
Yan Gong,
Mohamed H. Shahin,
Stephen T. Turner,
Arlene B. Chapman,
John G. Gums,
Stephen H. Boyle,
Hongjie Zhu,
William R. Wikoff,
Eric Boerwinkle,
Oliver Fiehn,
Reginald F. Frye,
Rima KaddurahDaouk,
Julie A. Johnson
Publication year - 2014
Publication title -
circulation cardiovascular genetics
Language(s) - English
Resource type - Journals
eISSN - 1942-325X
pISSN - 1942-3268
DOI - 10.1161/circgenetics.113.000421
Subject(s) - valine , medicine , phenylalanine , impaired fasting glucose , endocrinology , diabetes mellitus , isoleucine , leucine , pharmacology , insulin resistance , chemistry , amino acid , biochemistry , impaired glucose tolerance
The 5-amino acid (AA) signature, including isoleucine, leucine, valine, tyrosine, and phenylalanine, has been associated with incident diabetes mellitus and insulin resistance. We investigated whether this same AA signature, single-nucleotide polymorphisms in genes in their catabolic pathway, was associated with development of impaired fasting glucose (IFG) after atenolol treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom